Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Andrology

  Free Subscription


Articles published in Prostate

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    June 2017
  1. PEJCIC T, Tosti T, Tesic Z, Milkovic B, et al
    Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
    Prostate. 2017 Jun 8. doi: 10.1002/pros.23365.
    PubMed     Text format     Abstract available


  2. NYGARD LH, Talala K, Taari K, Tammela TLJ, et al
    The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia.
    Prostate. 2017;77:1029-1035.
    PubMed     Text format     Abstract available


    April 2017
  3. GONCALVES BF, de Campos SG, Goes RM, Scarano WR, et al
    Dual action of high estradiol doses on MNU-induced prostate neoplasms in a rodent model with high serum testosterone: Protective effect and emergence of unstable epithelial microenvironment.
    Prostate. 2017 Apr 12. doi: 10.1002/pros.23353.
    PubMed     Text format     Abstract available


    February 2017
  4. INAMURA S, Shinagawa T, Hoshino H, Sakai Y, et al
    Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
    Prostate. 2017 Feb 9. doi: 10.1002/pros.23319.
    PubMed     Text format     Abstract available


    December 2016
  5. KLAASSEN Z, Howard LE, Moreira DM, Andriole GL Jr, et al
    Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
    Prostate. 2016 Dec 19. doi: 10.1002/pros.23285.
    PubMed     Text format     Abstract available


  6. ZHOU Y, Copeland B, Otto-Duessel M, He M, et al
    Low Testosterone Alters the Activity of Mouse Prostate Stem Cells.
    Prostate. 2016 Dec 14. doi: 10.1002/pros.23290.
    PubMed     Text format     Abstract available


    November 2016
  7. WALLUKAT G, Jandrig B, Kunze R, Wendler JJ, et al
    Autoantibodies Directed Against the Endothelin A Receptor in Patients With Benign Prostatic Hyperplasia.
    Prostate. 2016 Nov 24. doi: 10.1002/pros.23284.
    PubMed     Text format     Abstract available


  8. REGIS L, Planas J, Carles J, Maldonado X, et al
    Free Testosterone During Androgen Deprivation Therapy Predicts Castration-Resistant Progression Better Than Total Testosterone.
    Prostate. 2016 Nov 1. doi: 10.1002/pros.23256.
    PubMed     Text format     Abstract available


    October 2016
  9. CAPOGROSSO P, Ventimiglia E, Moschini M, Boeri L, et al
    Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine.
    Prostate. 2016 Oct 24. doi: 10.1002/pros.23266.
    PubMed     Text format     Abstract available


    July 2016
  10. NAKATA D, Nakayama K, Masaki T, Tanaka A, et al
    Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
    Prostate. 2016 Jul 30. doi: 10.1002/pros.23238.
    PubMed     Text format     Abstract available


  11. RUSSO GI, Cimino S, Castelli T, Favilla V, et al
    Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
    Prostate. 2016 Jul 25. doi: 10.1002/pros.23237.
    PubMed     Text format     Abstract available


  12. GU NY, Kim JH, Han IH, Im SJ, et al
    Trichomonas vaginalis induces IL-1beta production in a human prostate epithelial cell line by activating the NLRP3 inflammasome via reactive oxygen species and potassium ion efflux.
    Prostate. 2016;76:885-96.
    PubMed     Text format     Abstract available


    June 2016
  13. KIM JH, Kim SS, Han IH, Sim S, et al
    Proliferation of prostate stromal cell induced by benign prostatic hyperplasia epithelial cell stimulated with Trichomonas vaginalis via crosstalk with mast cell.
    Prostate. 2016 Jun 21. doi: 10.1002/pros.23227.
    PubMed     Text format     Abstract available


  14. GERRIN SJ, Sowalsky AG, Balk SP, Ye H, et al
    Mutation profiling indicates high grade prostatic intraepithelial neoplasia as distant precursors of adjacent invasive prostatic adenocarcinoma.
    Prostate. 2016 Jun 8. doi: 10.1002/pros.23212.
    PubMed     Text format     Abstract available


    April 2016
  15. AUSTIN DC, Strand DW, Love HL, Franco OE, et al
    NF-kappaB and androgen receptor variant expression correlate with human BPH progression.
    Prostate. 2016;76:491-511.
    PubMed     Text format     Abstract available


    March 2016
  16. CHA YJ, Lee JH, Han HH, Kim BG, et al
    MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Prostate. 2016 Mar 28. doi: 10.1002/pros.23183.
    PubMed     Text format     Abstract available


    February 2016
  17. NIRAULA S, Templeton AJ, Vera-Badillo FE, Joshua AM, et al
    Study of testosterone-guided androgen deprivation therapy in management of prostate cancer.
    Prostate. 2016;76:235-42.
    PubMed     Text format     Abstract available


    January 2016
  18. LEE SS, Yang YW, Tsai TH, Kuo YH, et al
    5-alpha-reductase inhibitors and the risk of diabetes mellitus: A nationwide population-based study.
    Prostate. 2016;76:41-7.
    PubMed     Text format     Abstract available


    November 2015
  19. HOLMSTROM F, Shimizu S, Shimizu T, Higashi Y, et al
    Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.
    Prostate. 2015;75:1774-82.
    PubMed     Text format     Abstract available


    September 2015
  20. VITAL P, Castro P, Ittmann M
    Oxidative stress promotes benign prostatic hyperplasia.
    Prostate. 2015 Sep 29. doi: 10.1002/pros.23100.
    PubMed     Text format     Abstract available


  21. LIU Y, Zhao X, Sun X, Li Y, et al
    Expression of IL-17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia.
    Prostate. 2015 Sep 10. doi: 10.1002/pros.23058.
    PubMed     Text format     Abstract available


    August 2015
  22. LATIL A, Petrissans MT, Rouquet J, Robert G, et al
    Effects of hexanic extract of serenoa repens (permixon 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
    Prostate. 2015 Aug 26. doi: 10.1002/pros.23059.
    PubMed     Text format     Abstract available


    July 2015
  23. THOMAS LN, Merrimen J, Bell DG, Rendon R, et al
    Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
    Prostate. 2015 Jul 22. doi: 10.1002/pros.23054.
    PubMed     Text format     Abstract available


    June 2015
  24. NAKATA W, Nakai Y, Yoshida T, Sato M, et al
    Bone marrow-derived cells contribute to regeneration of injured prostate epithelium and stroma.
    Prostate. 2015;75:806-14.
    PubMed     Text format     Abstract available


    May 2015
  25. BERNICHTEIN S, Pigat N, Camparo P, Latil A, et al
    Anti-inflammatory properties of Lipidosterolic extract of Serenoa repens (Permixon(R)) in a mouse model of prostate hyperplasia.
    Prostate. 2015;75:706-22.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Andrology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: